Patients who received heart transplants from hepatitis C virus-positive vs -negative donors were found to have comparable survival at 1 year and patients who developed transplant-related hepatitis C responded well to treatment.
Untreated chronic oral infection is not associated with post-hematopoietic stem cell transplant outcomes.
Adult heart transplants from hepatitis C virus-positive donors appear safe, with no increased risk for adverse effects on one-year survival.
Many pediatric liver transplant recipients are undervaccinated.
Early-onset pneumonia with multidrug-resistant organisms is a major concern for patients who have received a liver transplant, and pre- and intra-operative risk factors influence its development, according to study data presented at The American Association for the Study of Liver Diseases’ The Liver Meeting, held November 8 to 12, 2019 in Boston, Massachusetts. In an…
Managing the risk for infection is one of the primary tasks in optimizing outcomes for solid organ transplant recipients.
The epidemiology of acute gastroenteritis pathogens identified from pediatric patients who have undergone allogenic hematopoietic cell transplant may be changing.
Patients with recurrent Clostridioides difficile infection who receive treatment with fecal microbiota transplantation are less likely to develop a primary bloodstream infection.
Patients with established chronic lung allograft dysfunction may have a higher risk for respiratory syncytial virus infections, but lung function decline does not appear to be significantly affected.
Bloodstream infections are common in patients who have received a solid organ transplants.
